KODIAK SCIENCES INC (KOD:NASDAQ)
$90.99 3.36 (3.8343%)
Analysed KODIAK SCIENCES INC (KOD:NASDAQ) News Sources
Kodiak Sciences (KOD) Climbs Nearly 3x on Promising Wet AMD Trial
28-09-2026
yahoo.com
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’
29-09-2026
stocktwits.com
Why Kodiak Sciences Skyrocketed Today
29-09-2026
fool.com
A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?
30-09-2026
247wallst.com
Kodiak Sciences More Than Doubles on Eye Disease Trial Results
01-10-2026
barchart.com
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
02-10-2026
biopharmadive.com
Kodiak Sciences’ Two Wet AMD Treatments Match Aflibercept in Phase III Study
02-10-2026
marketbeat.com
Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026
07-10-2026
yahoo.com
Kodiak Sciences (KOD) Stock Trades At A Premium On DAYBREAK Trial News
08-10-2026
yahoo.com
Kodiak Sciences (KOD) Could Be 7% Overvalued Following Late Stage Data Update
08-10-2026
yahoo.com
What is the current price of KODIAK SCIENCES INC (KOD:NASDAQ)?
The current price of KODIAK SCIENCES INC (KOD:NASDAQ) is $90.99.
KODIAK SCIENCES INC (KOD:NASDAQ) absolute price change since previous trading day?
The absolute price change of KODIAK SCIENCES INC (KOD:NASDAQ) since the previous trading day is $3.36.
KODIAK SCIENCES INC (KOD:NASDAQ) percentage price change since previous trading day?
The percentage price change of KODIAK SCIENCES INC (KOD:NASDAQ) since the previous trading day is 3.8343%.
What is the most recent average sentiment score for KODIAK SCIENCES INC (KOD:NASDAQ)?
The most recent average sentiment score for KODIAK SCIENCES INC (KOD:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for KODIAK SCIENCES INC (KOD:NASDAQ)?
The most recent sentiment for KODIAK SCIENCES INC (KOD:NASDAQ) is .
SEC-8K** Filing Available For KODIAK SCIENCES INC (KOD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.